Traws Pharma Investor Relations Material
Latest events
Q2 2025
Traws Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Traws Pharma Inc
Access all reports
Traws Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the development of oral small molecule therapies for respiratory viral diseases and cancer. The company focuses on creating novel treatments for conditions such as influenza, COVID-19, and various cancers, utilizing advanced drug development technologies including artificial intelligence and machine learning. The company is headquartered in Newtown, Pennsylvania, and its shares are listed on NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TRAW
Country
🇺🇸 United States